GLG LLC’s Lexicon Pharmaceuticals LXRX Stock Holding History

GLG LLC’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-56,928	Closed	-$363K	–	642
2014 Q4	$363K	Buy	+56,928	New	+$459K	0.01%	568

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

GLG LLC's LXRX Position: Q1 2015 in Review

GLG LLC sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2015, closing a stake of 56,928 shares — an estimated $363K sold.

GLG LLC first reported a position in LXRX in Q4 2014 and held it in 1 quarter. The position peaked at $363K in Q4 2014. 119 funds tracked by Wall St. Rank hold LXRX as of Q1 2015.

GLG LLC reported no remaining Lexicon Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
GLG LLC sold 56,928 Lexicon Pharmaceuticals shares in Q1 2015, an estimated $363K.
GLG LLC first reported a position in Lexicon Pharmaceuticals in Q4 2014 and held it in 1 quarter.
GLG LLC's Lexicon Pharmaceuticals position peaked at $363K in Q4 2014.
119 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2015.

Based on GLG LLC's 13F filing for Q1 2015, filed 15 May 2015.